Interferon gamma release assay (original) (raw)
Interferon-γ release assays (IGRA) are medical tests used in the diagnosis of some infectious diseases, especially tuberculosis. Interferon-γ (IFN-γ) release assays rely on the fact that T-lymphocytes will release IFN-γ when exposed to specific antigens. These tests are mostly developed for the field of tuberculosis diagnosis, but in theory, may be used in the diagnosis of other diseases which rely on cell-mediated immunity, e.g. cytomegalovirus and leishmaniasis. For example, in patients with cutaneous adverse drug reactions, challenge of peripheral blood lymphocytes with the drug causing the reaction produced a positive test result for half of the drugs tested.
| Property | Value |
|---|---|
| dbo:abstract | Interferon-γ release assays (IGRA) are medical tests used in the diagnosis of some infectious diseases, especially tuberculosis. Interferon-γ (IFN-γ) release assays rely on the fact that T-lymphocytes will release IFN-γ when exposed to specific antigens. These tests are mostly developed for the field of tuberculosis diagnosis, but in theory, may be used in the diagnosis of other diseases which rely on cell-mediated immunity, e.g. cytomegalovirus and leishmaniasis. For example, in patients with cutaneous adverse drug reactions, challenge of peripheral blood lymphocytes with the drug causing the reaction produced a positive test result for half of the drugs tested. There are currently two IFN-γ release assays available for the diagnosis of tuberculosis: * QuantiFERON-TB Gold (licensed in US, Europe and Japan); and * T-SPOT.TB, a form of ELISpot, the variant of ELISA (licensed in Europe, US, Japan and China). The former test quantitates the amount of IFN-γ produced in response to the ESAT-6 and CFP-10 antigens from Mycobacterium tuberculosis, which are distinguishable from those present in BCG and most other non-tuberculous mycobacteria. The latter test determines the total number of individual effector T cells expressing IFN-γ. The indications for the test are still disputed. It has been evaluated for the diagnosis of latent tuberculosis in HIV patients (who frequently have a negative Mantoux test). (en) |
| dbo:wikiPageID | 9334285 (xsd:integer) |
| dbo:wikiPageLength | 2496 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID | 1106039298 (xsd:integer) |
| dbo:wikiPageWikiLink | dbr:Cytomegalovirus dbr:ELISA dbr:ELISpot dbr:ESAT-6 dbr:Leishmaniasis dbr:Tuberculosis dbc:Tuberculosis dbr:Cutaneous dbr:Adverse_drug_reaction dbr:CFP-10 dbr:Mantoux_test dbr:T-SPOT.TB dbr:Tuberculosis_diagnosis dbr:Bacille_Calmette-Guérin dbr:IFN-γ dbr:Effector_T_cells dbr:QuantiFERON-TB_Gold dbr:Mycobacteria dbr:Interferon-γ dbr:Wikt:antigen |
| dbp:wikiPageUsesTemplate | dbt:Cn dbt:Reflist dbt:Tuberculosis |
| dcterms:subject | dbc:Tuberculosis |
| gold:hypernym | dbr:Tests |
| rdf:type | dbo:GolfCourse |
| rdfs:comment | Interferon-γ release assays (IGRA) are medical tests used in the diagnosis of some infectious diseases, especially tuberculosis. Interferon-γ (IFN-γ) release assays rely on the fact that T-lymphocytes will release IFN-γ when exposed to specific antigens. These tests are mostly developed for the field of tuberculosis diagnosis, but in theory, may be used in the diagnosis of other diseases which rely on cell-mediated immunity, e.g. cytomegalovirus and leishmaniasis. For example, in patients with cutaneous adverse drug reactions, challenge of peripheral blood lymphocytes with the drug causing the reaction produced a positive test result for half of the drugs tested. (en) |
| rdfs:label | Interferon gamma release assay (en) インターフェロンγ遊離試験 (ja) |
| owl:sameAs | freebase:Interferon gamma release assay wikidata:Interferon gamma release assay dbpedia-ja:Interferon gamma release assay dbpedia-vi:Interferon gamma release assay https://global.dbpedia.org/id/4nn9w |
| prov:wasDerivedFrom | wikipedia-en:Interferon_gamma_release_assay?oldid=1106039298&ns=0 |
| foaf:isPrimaryTopicOf | wikipedia-en:Interferon_gamma_release_assay |
| is dbo:wikiPageDisambiguates of | dbr:IGRA |
| is dbo:wikiPageRedirects of | dbr:Gamma_interferon_assay dbr:Interferon-g_release_assays dbr:Interferon-γ_release_assays dbr:Interferon_g_test dbr:Interferon-gamma_release_assay dbr:Interferon-gamma_release_test dbr:Interferon-γ_release_assay dbr:Interferon_γ_test |
| is dbo:wikiPageWikiLink of | dbr:QuantiFERON dbr:Gamma_interferon_assay dbr:BCG_vaccine dbr:Tuberculosis dbr:Latent_tuberculosis dbr:Interferon_gamma dbr:IGRA dbr:Mantoux_test dbr:Tuberculoma dbr:Interferon-g_release_assays dbr:Interferon-γ_release_assays dbr:Interferon_g_test dbr:T-SPOT.TB dbr:Interferon-gamma_release_assay dbr:Interferon-gamma_release_test dbr:Interferon-γ_release_assay dbr:Interferon_γ_test |
| is foaf:primaryTopic of | wikipedia-en:Interferon_gamma_release_assay |